KRISTINA RENFROW: Open Payments
NPI 1346765617 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,939 in 108 payments from 30 companies in 2025. Trend: 2023 $2,121 · 2024 $1,943 · 2025 $1,939
Food & beverage: $1,939
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $365 |
| PFIZER INC. | 10 | $154 |
| Neurocrine BioSciences, Inc. | 5 | $117 |
| Amneal Pharmaceuticals LLC | 4 | $99 |
| LivaNova USA, Inc. | 4 | $98 |
| HARMONY BIOSCIENCES LLC | 2 | $79 |
| Lilly USA, LLC | 4 | $76 |
| Amgen Inc. | 4 | $75 |
| Axsome Therapeutics, Inc. | 4 | $75 |
| Eisai Inc. | 3 | $71 |
Products named: UBRELVY, NURTEC ODT, INGREZZA, CREXONT, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, WAKIX, REXULTI, UPLIZNA.
Industry payments across IN — which companies pay providers there.
